Legend Capital-backed clinical services provider R&G Pharmastudies floated in a $174m initial public offering while several corporates exited Pymetrics in an acquisition by Harver.

Public markets

Legend Capital, the venture capital firm formed by conglomerate Legend Holdings, has exited China-based contract clinical services provider R&G Pharmastudies in a $174m initial public offering on Shenzhen Stock Exchange’s Chinext market. The firm did not disclosed how much funding it had provided for R&G but said it first invested through a 2017 series A round.

M&A

Recuitment software producer Harver has paid an undisclosed sum to acquire Pymetrics, a US-based skills assessment software provider backed by several corporates. Pymetrics graduated from consulting firm Accenture’s FinTech Innovation Lab and had raised a total of nearly $57m as of 2018, from investors including recruitment firm Randstad’s Innovation Fund and professional services firm Marsh & McLennan’s Mercer subsidiary as well as Salesforce Ventures and Workday Ventures, on behalf of enterprise software producers Salesforce and Workday respectively.

Company name Company description Sector Country Round Round Size ($) Deal date Investors
FundamentalVR Surgical simulation software…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Roshini Bains

Roshini Bains is the junior news reporter for Global Corporate Venturing and Global University Venturing.
email
Linked in

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Find out more

Featured Content

FUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.
RISING STARS Introducing the GCV Rising Stars 2024

RISING STARS

Introducing the GCV Rising Stars 2024
EMERGING LEADERS Introducing the GCV Emerging Leaders 2024

EMERGING LEADERS

Introducing the GCV Emerging Leaders 2024
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
Find out more All events
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Find out more All events
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
Find out more All events
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Find out more All events
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Find out more All events
Top News
  Leontiou heads Eurobank's CVC
Meet the corporations investing in data centre energy startups
11 data centre energy startups to watch
Next47 hires Cheng for partner role
Turk promoted at Allison Ventures
The big debate: Should board seats go to CVCs or business units?

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.

 

Navigation

 

© 2024 Mawsonia Ltd. All rights reserved.
test reg